HRP20060023A2 - Use of bicyclo[2.2.1]heptane derivatives for the preparation of neuroprotective pharmaceutical compositions - Google Patents
Use of bicyclo[2.2.1]heptane derivatives for the preparation of neuroprotective pharmaceutical compositionsInfo
- Publication number
- HRP20060023A2 HRP20060023A2 HR20060023A HRP20060023A HRP20060023A2 HR P20060023 A2 HRP20060023 A2 HR P20060023A2 HR 20060023 A HR20060023 A HR 20060023A HR P20060023 A HRP20060023 A HR P20060023A HR P20060023 A2 HRP20060023 A2 HR P20060023A2
- Authority
- HR
- Croatia
- Prior art keywords
- preparation
- pharmaceutical compositions
- bicyclo
- heptane derivatives
- neuroprotective pharmaceutical
- Prior art date
Links
- 230000000324 neuroprotective effect Effects 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- UMRZSTCPUPJPOJ-KNVOCYPGSA-N norbornane Chemical class C1C[C@H]2CC[C@@H]1C2 UMRZSTCPUPJPOJ-KNVOCYPGSA-N 0.000 title 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0301906A HUP0301906A3 (en) | 2003-06-23 | 2003-06-23 | Use of bicyclo[2.2.1]heptane derivatives for producing of pharmaceutical compositions having neuroprotectiv activity |
PCT/HU2004/000062 WO2004112769A1 (en) | 2003-06-23 | 2004-06-22 | Use of bicyclo[2.2.1]heptane derivatives for the preparation of neuroprotective pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20060023A2 true HRP20060023A2 (en) | 2006-05-31 |
Family
ID=90001689
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20060023A HRP20060023A2 (en) | 2003-06-23 | 2006-01-17 | Use of bicyclo[2.2.1]heptane derivatives for the preparation of neuroprotective pharmaceutical compositions |
Country Status (23)
Country | Link |
---|---|
US (1) | US20060258750A1 (xx) |
EP (1) | EP1660063A1 (xx) |
JP (1) | JP2007516165A (xx) |
KR (1) | KR20060023997A (xx) |
CN (1) | CN1812778A (xx) |
AU (1) | AU2004248982A1 (xx) |
BG (1) | BG109414A (xx) |
BR (1) | BRPI0411772A (xx) |
CA (1) | CA2529254A1 (xx) |
CZ (1) | CZ200631A3 (xx) |
EA (1) | EA010868B1 (xx) |
HR (1) | HRP20060023A2 (xx) |
HU (1) | HUP0301906A3 (xx) |
IL (1) | IL172408A0 (xx) |
IS (1) | IS8239A (xx) |
MX (1) | MXPA05014127A (xx) |
NO (1) | NO20060277L (xx) |
PL (1) | PL378630A1 (xx) |
RS (1) | RS20050954A (xx) |
SK (1) | SK50082006A3 (xx) |
UA (1) | UA81052C2 (xx) |
WO (1) | WO2004112769A1 (xx) |
ZA (1) | ZA200510138B (xx) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2400300A1 (en) | 2004-08-25 | 2011-12-28 | Takeda Pharmaceutical Company Limited | Method of screening preventives/remedies for stress urinary incontinence |
EP2018863B9 (en) | 2006-05-16 | 2015-02-18 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound and use thereof |
JP5520051B2 (ja) | 2007-11-15 | 2014-06-11 | 武田薬品工業株式会社 | 縮合ピリジン誘導体およびその用途 |
CZ301168B6 (cs) * | 2008-10-09 | 2009-11-25 | Ústav chemických procesu Akademie ved Ceské republiky | Zpusob a zarízení pro izolaci kyseliny tereftalové |
JPWO2011071136A1 (ja) | 2009-12-11 | 2013-04-22 | アステラス製薬株式会社 | 線維筋痛症治療剤 |
US11478467B2 (en) | 2017-05-04 | 2022-10-25 | Sreenivasarao Vepachedu | Targeted drug rescue with novel compositions, combinations, and methods thereof |
US20210052600A1 (en) | 2017-12-27 | 2021-02-25 | Takeda Pharmaceutical Company Limited | Therapeutic agents for stress urinary incontinence and incotinence of feces |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU227114B1 (en) * | 1999-05-11 | 2010-07-28 | Egis Gyogyszergyar Nyilvanosan | (1r, 2s, 4r)-(-)-2-[n,n-(dimethylamino-ethoxy)]-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane of high purity and pharmaceutically acceptable acid addition salts thereof, process for preparation of them and medicaments containing the same |
US6335371B1 (en) * | 2000-11-28 | 2002-01-01 | Orion Corporation | Method for inducing cognition enhancement |
HUP0103017A3 (en) * | 2001-07-18 | 2004-05-28 | Egis Gyogyszergyar Nyilvanosan | Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use |
-
2003
- 2003-06-23 HU HU0301906A patent/HUP0301906A3/hu unknown
-
2004
- 2004-06-22 JP JP2006516495A patent/JP2007516165A/ja active Pending
- 2004-06-22 US US10/562,393 patent/US20060258750A1/en not_active Abandoned
- 2004-06-22 EP EP04743721A patent/EP1660063A1/en not_active Withdrawn
- 2004-06-22 SK SK5008-2006A patent/SK50082006A3/sk not_active Application Discontinuation
- 2004-06-22 CN CNA2004800177453A patent/CN1812778A/zh active Pending
- 2004-06-22 PL PL378630A patent/PL378630A1/pl not_active Application Discontinuation
- 2004-06-22 BR BRPI0411772-7A patent/BRPI0411772A/pt not_active IP Right Cessation
- 2004-06-22 WO PCT/HU2004/000062 patent/WO2004112769A1/en active Application Filing
- 2004-06-22 AU AU2004248982A patent/AU2004248982A1/en not_active Abandoned
- 2004-06-22 RS YUP-2005/0954A patent/RS20050954A/sr unknown
- 2004-06-22 ZA ZA200510138A patent/ZA200510138B/xx unknown
- 2004-06-22 UA UAA200600574A patent/UA81052C2/uk unknown
- 2004-06-22 MX MXPA05014127A patent/MXPA05014127A/es not_active Application Discontinuation
- 2004-06-22 CA CA002529254A patent/CA2529254A1/en not_active Abandoned
- 2004-06-22 KR KR1020057024601A patent/KR20060023997A/ko not_active Application Discontinuation
- 2004-06-22 EA EA200600022A patent/EA010868B1/ru not_active IP Right Cessation
-
2005
- 2005-12-06 IL IL172408A patent/IL172408A0/en unknown
-
2006
- 2006-01-16 CZ CZ20060031A patent/CZ200631A3/cs unknown
- 2006-01-17 HR HR20060023A patent/HRP20060023A2/xx not_active Application Discontinuation
- 2006-01-18 IS IS8239A patent/IS8239A/is unknown
- 2006-01-19 NO NO20060277A patent/NO20060277L/no not_active Application Discontinuation
- 2006-01-23 BG BG109414A patent/BG109414A/bg unknown
Also Published As
Publication number | Publication date |
---|---|
UA81052C2 (en) | 2007-11-26 |
KR20060023997A (ko) | 2006-03-15 |
CA2529254A1 (en) | 2004-12-29 |
EA010868B1 (ru) | 2008-12-30 |
US20060258750A1 (en) | 2006-11-16 |
CZ200631A3 (cs) | 2006-05-17 |
MXPA05014127A (es) | 2006-02-24 |
HUP0301906A2 (en) | 2006-02-28 |
HUP0301906A3 (en) | 2006-03-28 |
CN1812778A (zh) | 2006-08-02 |
IS8239A (is) | 2006-01-18 |
BRPI0411772A (pt) | 2006-08-08 |
NO20060277L (no) | 2006-01-19 |
JP2007516165A (ja) | 2007-06-21 |
RS20050954A (xx) | 2007-08-03 |
HUP0301906D0 (en) | 2003-08-28 |
EP1660063A1 (en) | 2006-05-31 |
WO2004112769A1 (en) | 2004-12-29 |
SK50082006A3 (sk) | 2006-05-04 |
AU2004248982A1 (en) | 2004-12-29 |
BG109414A (bg) | 2006-11-30 |
IL172408A0 (en) | 2006-04-10 |
PL378630A1 (pl) | 2006-05-15 |
ZA200510138B (en) | 2007-03-28 |
EA200600022A1 (ru) | 2006-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1340755A4 (en) | AGENT WITH EFFECT AGAINST HELICOBACTER | |
BR0108894A (pt) | Composição farmacêutica, compostos e processo de preparação de compostos | |
HRP20060023A2 (en) | Use of bicyclo[2.2.1]heptane derivatives for the preparation of neuroprotective pharmaceutical compositions | |
HRP20050663A2 (en) | Malonamide derivatives as gamma-secretase inhibitors | |
HUP0402649A2 (hu) | 6-Fluor-biciklo[3.1.0]hexán-származékok | |
ATE297910T1 (de) | Retinoid x rezeptormodulatoren | |
NO20062098L (no) | Faststofftilstandmontelukast | |
UY27368A1 (es) | Nuevos compuestos | |
BRPI0110955B8 (pt) | derivados de tropano composição farmacêutica, uso dos mesmos na fabricação de um medicamento bem como processo para a preparação dos mesmos. | |
ATE297203T1 (de) | Antithrombotische mitteln | |
ATE241617T1 (de) | Pyrimidinverbindungen | |
CU23240B7 (es) | Derivados de 2-aminocarbonil-9h-purina | |
ATE506354T1 (de) | Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren | |
MX2007005694A (es) | Nuevos derivados de betulina, preparacion y uso de los mismos. | |
YU43001A (sh) | Supstituisani biciklični derivati korisni kao sredstva protiv kancera | |
AU2001280438A1 (en) | Substituted heterocyclic amides | |
DE602005019316D1 (en) | Aromatische etherderivate als thrombin-hemmer | |
MXPA05011411A (es) | 1,4-diazepinas sustituidas y usos de las mismas. | |
ECSP067111A (es) | Derivados de pirido-pirimidina, su preparación, su aplicación en terapéutica | |
ECSP077402A (es) | Derivados de 2-amido-4-feniltiazol, su preparación y su aplicación en terapéutica | |
PE20050012A1 (es) | Compuestos de benzopirano como inhibidores de la ciclooxigenasa-2 | |
HUP0401235A2 (hu) | 5-HT6 receptor affinitással rendelkező arilszulfonil-származékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyászati készítmények | |
BR0312798A (pt) | Derivados de isotiazol úteis como agentes anticancerìgenos | |
ATE308540T1 (de) | Antithrombosemittel | |
DE69512208D1 (de) | Aminosäurederivate und ihre verwendung als phospholipase-a2-inhibitoren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
AIPI | Request for the grant of a patent on the basis of a substantive examination of a patent application | ||
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20080604 Year of fee payment: 5 |
|
OBST | Application withdrawn |